Oymak O - Search Results

1

Kocyigit I, Yilmaz MI, Gungor O, Eroglu E, Unal A, Orscelik O, Tokgoz B, Sipahioglu M, Sen A, Carrero JJ, Oymak O, Axelsson J. Kocyigit I, et al. Among authors: oymak o. BMC Nephrol. 2016 Nov 30;17(1):196. doi: 10.1186/s12882-016-0406-4. BMC Nephrol. 2016. PMID: 27899079 Free PMC article.

2

Does retinitis pigmentosa relate with polycystic kidney disease?

Koçyigit I, Unal A, Ozaslan E, Oymak O, Utas C. Koçyigit I, et al. Among authors: oymak o. Int Urol Nephrol. 2010 Dec;42(4):1103-5. doi: 10.1007/s11255-010-9709-8. Epub 2010 Jan 29. Int Urol Nephrol. 2010. PMID: 20111998

3

Effect of serum electrolyte and bicarbonate concentration changes during hemodialysis sessions on heart rate variability.

Sipahioglu MH, Kocyigit I, Unal A, Karakurt M, Celik A, Tokgoz B, Oymak O, Utas C. Sipahioglu MH, et al. Among authors: oymak o. J Nephrol. 2012 Nov-Dec;25(6):1067-74. doi: 10.5301/jn.5000098. J Nephrol. 2012. PMID: 22383344

4

Role of neutrophil/lymphocyte ratio in prediction of disease progression in patients with stage-4 chronic kidney disease.

Kocyigit I, Eroglu E, Unal A, Sipahioglu MH, Tokgoz B, Oymak O, Utas C. Kocyigit I, et al. Among authors: oymak o. J Nephrol. 2013 Mar-Apr;26(2):358-65. doi: 10.5301/jn.5000152. Epub 2012 May 8. J Nephrol. 2013. PMID: 22573523

5

Early arterial stiffness and inflammatory bio-markers in normotensive polycystic kidney disease patients.

Kocyigit I, Kaya MG, Orscelik O, Kaya C, Akpek M, Zengin H, Sipahioglu MH, Unal A, Yilmaz MI, Tokgoz B, Oymak O, Axelsson J. Kocyigit I, et al. Among authors: oymak o. Am J Nephrol. 2012;36(1):11-8. doi: 10.1159/000339440. Epub 2012 Jun 13. Am J Nephrol. 2012. PMID: 22699414

6

Mean platelet volume and its relation with arterial stiffness in patients with normotensive polycystic kidney disease.

Orscelik O, Kocyigit I, Akpek M, Dogdu O, Kaya C, Unal A, Sipahioglu M, Tokgoz B, Zengin H, Oymak O, Kaya MG. Orscelik O, et al. Among authors: oymak o. J Investig Med. 2013 Mar;61(3):597-603. doi: 10.2310/JIM.0b013e31828218e7. J Investig Med. 2013. PMID: 23360844

7

Serum uric acid levels and endothelial dysfunction in patients with autosomal dominant polycystic kidney disease.

Kocyigit I, Yilmaz MI, Orscelik O, Sipahioglu MH, Unal A, Eroglu E, Kalay N, Tokgoz B, Axelsson J, Oymak O. Kocyigit I, et al. Among authors: oymak o. Nephron Clin Pract. 2013;123(3-4):157-64. doi: 10.1159/000353730. Epub 2013 Jul 25. Nephron Clin Pract. 2013. PMID: 23887359 Clinical Trial.

8

A link between the intrarenal renin angiotensin system and hypertension in autosomal dominant polycystic kidney disease.

Kocyigit I, Yilmaz MI, Unal A, Ozturk F, Eroglu E, Yazici C, Orscelik O, Sipahioglu MH, Tokgoz B, Oymak O. Kocyigit I, et al. Among authors: oymak o. Am J Nephrol. 2013;38(3):218-25. doi: 10.1159/000354317. Epub 2013 Aug 28. Am J Nephrol. 2013. PMID: 23988725

9

Pentraxin 3 as a novel bio-marker of inflammation and endothelial dysfunction in autosomal dominant polycystic kidney disease.

Kocyigit I, Eroglu E, Orscelik O, Unal A, Gungor O, Ozturk F, Karakukcu C, Imamoglu H, Sipahioglu MH, Tokgoz B, Oymak O. Kocyigit I, et al. Among authors: oymak o. J Nephrol. 2014 Apr;27(2):181-6. doi: 10.1007/s40620-014-0045-4. Epub 2014 Feb 11. J Nephrol. 2014. PMID: 24515315

10

Effects of dialysis solution on the cardiovascular function in peritoneal dialysis patients.

Kocyigit I, Unal A, Gungor O, Orscelik O, Eroglu E, Dogan E, Sen A, Yasan M, Hayri Sipahioglu M, Tokgoz B, Dogan A, Oymak O. Kocyigit I, et al. Among authors: oymak o. Intern Med. 2015;54(1):3-10. doi: 10.2169/internalmedicine.54.2763. Epub 2015 Jan 1. Intern Med. 2015. PMID: 25742886 Free article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

141 results

Search Page

Filters